7th Diabetes Drug Discovery and Development Conference on April 23-25, 2014 in Cambridge, MA
weblink: http://www.gtcbio.com/conference/diabetes-drug-discovery-and-development-overview?utm_source=post+conference&utm_medium=website&utm_campaign=diabetesdd
Come and join diabetes experts at GTC’s 7th Diabetes Drug Discovery and Development Conference on April 23-25, 2014 in Cambridge, MA and hear key thought-leader's opinions on the next block-buster drug target for T1DM and T2DM and discuss how FDA guidance affects approaches to developing new medications.
The conference is part of GTC's annual Diabetes Summit which includes two co-located conferences:
7th Diabetes Drug Discovery and Development
4th Diabetes Partnering and Deal-Making
GTC's Drug Discovery and Development conference will bring together the leading experts on diabetes from academia, government, small/medium size biotech, big pharma and healthcare organizations to discuss research on various novel targets, programs in developments, regulatory guidance and other relevant insights that can help guests advance their own research.
Below is the preliminary program. For further detailed information, follow the links below:
To view the 2014 detailed agenda, click here.
To view the 2014 speaker list, click here.
2014 PROGRAM AT A GLANCE
April 23, 2014
General Session
Joint sessions with Diabetes Summit and 2014 Stem Cell Summit
Topics:
I. Cell Therapy and Diabetes - Stem Cell Research in the Diabetes Space
II. Cell Therapy Commercialization Model
Panel Discussions:
I. Acquisitions & Collaborative Environment in the Diabetes Regenerative Field
Conference I:
4th Diabetes Partnering and Deal-Making
Conference II:
7th Diabetes Drug Discovery and Development
April 24-25, 2014
Plenary Keynote Session
• Riccardo Perfetti, Vice President Global Medical Affairs, Diabetes Division, Sanofi
• Hans-Juergen Woerle, Vice President and Head of Therapeutic Area Metabolism, Boehringer Ingelheim
• Steven E. Nissen, Chairman of Cardiovascular Medicine, Cleveland Clinic Foundation
Panel Discussion: Type 1 Diabetes: "The New Honeymoon that Last Decades" - Clinical trial opportunities and the new diverse type 1 diabetic population - can we more accurately predict complications?
Participants:
Denise Faustman, Harvard Medical School
Deneen Vojta, United Healthcare Services
Corinth Auld, Mercodia
Richard Oram, Exeter
Diabetes Partnering and Deal-Making
Continued Diabetes Drug Discovery and Development
Continued
Sessions:
I. Innovative Partnering & Licensing Strategies
II. Partnering Opportunities in Diabetes Drug Development
III. Current Trends & Recent Deals
Panel Discussions:
I. Wining Strategies in Partnering & Deal-Making
II. Partnering with Non-Profits
III. Finding the Middle Ground in Big Pharma and Biotech Partnerships
IV. Partnering with Academia
V. Investment Opportunities in the Diabetes Space
VI. Strategies for Entry into Emerging Markets
VII. Evolving Landscape of the Insulin Market
For detailed agenda & participants click here
Sessions:
I. New Therapeutic Targets for Diabetes
II. Combination Therapy
III. Clinical Drug Development in Diabetes
Part 1: Type 1 Diabetes
Part 2: Type 2 Diabetes
IV. Advances in Obesity Drug Development
V. Diabetic Complications
Panel Discussion:
I. Beyond HbA1c – Are there Better Endpoints for Clinical Trials?
II. Med-Tech Advances for the Treatment of Diabetes
For detailed agenda & participants click here
The conference will run parallel with the 4th Diabetes Partnering and Deal Making conference.
Sign up for the summit pass to have access to both conferences of the summit. Or bring a team of 3 for the price of 2 by registering with the coupon code rcdvb!
We look forward to seeing you at the conference!
Best regards,
2014 Conference Advisory Committee
- Badges
- Science topic
- Similar topics
- Medicine
- Disease
- Metabolic Diseases
- Glucose Metabolism Disorders
- Diabetes